When considering a stem cell transplantation for a patient, many factors come in to play, especially in case of an allogeneic stem cell transplantation (allo SCT). The best donor and source of stem cells should be selected, the type of conditioning must be considered and the type of underlying disease and disease status at transplant also have an impact on the outcome of the transplantation. Additionally, survival post-transplant is influenced by the occurrence of graft versus host disease (GVHD), infections, or relapsed disease. Advances in different areas of allo SCT reported at the 2017 Annual Meeting of the American Society of Hematology (ASH) will be discussed in this summary.

(BELG J HEMATOL 2018;9(1):41–3)